The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction

<div>Survival curves of cardiovascular mortality. The Kaplan-Meier plots showing survival free of cardiovascular mortality in the total study collective (a) and patients stratified in ischemic HFrEF (b) as well as nonischemic HFrEF (c) according to tertiles of frequencies of regulatory T cells. Tertile 1 = low; tertile 2 = mid; tertile 3 = high.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction 

Figure 1 | The Prognostic Impact of Circulating Regulatory T Lymphocytes on Mortality in Patients with Ischemic Heart Failure with Reduced Ejection Fraction 